Philips and NHS implement the first regional data integration hub for UK’s National COVID-19 Chest Imaging Database
31 Marzo 2021 - 10:00AM
Philips and NHS implement the first regional data integration hub
for UK’s National COVID-19 Chest Imaging Database
March 31, 2021
- Cheshire and Merseyside consortium (NHS) is the first region to
have achieved this milestone for the UK’s National COVID-19 Chest
Imaging Database (NCCID)
- The deployment of a single SMART box server has provided access
to 15 years of imaging data across 2.5 million people in the
region, the largest single data source for NCCID
- Data integration capabilities as a result of this deployment
will allow Cheshire and Merseyside to validate the use of AI
technology across a variety of conditions
Amsterdam, the Netherlands and Guildford, United Kingdom
– Royal Philips (NYSE: PHG, AEX: PHIA), today announced it
has supported the NHS’ Cheshire and Merseyside consortium [1] to
become the first regional hub supplying the United Kingdom’s
National COVID-19 Chest Imaging Database (NCCID). The NCCID is a
centralized database containing X-Ray, CT and MRI images from
hospital patients across the country. It aims to support a better
understanding of the COVID-19 virus and develop AI-powered
technology which will enable the best care for patients
hospitalized with a severe infection [2]. This first regional hub
is integrating data across 13 NHS trusts in the consortium. The
deployment of a single centralized and secure server has provided
access to 15 years of imaging data across 2.5 million people in the
region, the largest single data source for NCCID.
The Cheshire and Merseyside consortium engaged with Philips to
help with enabling access to the entire region’s imaging data
through a single hub. Philips’ advanced data integration solution
for radiology, Philips Global worklist, was used to enable easy
integration with the NCIDD’s secure central SMART Box server that
will be required to support mass data collection, management and
de-identification and can facilitate multiple trials/research
projects simultaneously.
“One of the findings coming out of the end of this project will
definitely be to focus on regional hubs that will be able to
coordinate and better centralize the data, a hub just like Cheshire
and Merseyside,” said Prof Mark-Halling Brown, Head of Scientific
Computing at Royal Surrey NHS Foundation Trust. “It can take many
months or even years to set up SMART boxes at individual trusts, so
doing it regionally is the only way to scale up nationally.”
“Most District General Hospitals average 250,000 to 350,000
imaging exams per year,” said Steve Sparks, Professional Services
Manager Radiology Informatics at Philips UK&I. “With a single
regional SMART box we have been able to gain access to the images
from the 13 Trusts within the Cheshire and Merseyside
consortium.”
Save Radiologists’ time, increase the safety and
consistency of careThe NCCID database is developed in
collaboration with NHSX, an organization driving the digital
transformation of the NHS, The British Society of Thoracic Imaging
(BSTI) and The Royal Surrey NHS Foundation Trust. The database is
being used for the validation of AI products for use in the NHS,
aiding the diagnosis and treatment of COVID-19 in the UK
population. This data has the potential to enable quicker patient
assessment when arriving at hospital’s emergency departments, save
Radiologists’ time, increase the safety and consistency of care
across the country, and ultimately save lives. It is being made
available to researchers, clinicians, technology companies and all
those wanting to investigate the disease and develop solutions that
can support the COVID-19 patient care pathway.
The SMART box server technology will also enable Cheshire and
Merseyside to participate in research into many areas requiring
large volumes of clinical imaging data. The COVID-19 pandemic has
highlighted the potential for medical imaging systems powered by
AI. The NHS AI Lab, created last year within NHSX, is developing a
National Medical Imaging Platform with the purpose of creating a
pipeline for patient data to be used within AI technology across
conditions other than COVID-19. The NCCID is one workstream taken
forward by the NHS AI Lab at NHSX, which will accelerate the
safe, ethical, and effective adoption of AI in the healthcare
sector. The power of large-scale data collection has already been
demonstrated in various studies, including breast cancer screening
studies such as OPTIMAM. Setting up regional hubs, such as the
SMART box deployment in Cheshire and Merseyside, will aid the
creation of these large-scale National databases and AI technology
to help combat a variety of conditions.
Comprehensive portfolio for COVID-19 high-quality
carePhilips has a comprehensive portfolio of products,
services and solutions to support the delivery of high-quality care
to COVID-19 patients worldwide. Solutions include secure, connected
and intelligent approaches to diagnosis, treatment and predictive
monitoring in the hospital, plus screening, remote patient
monitoring and care at home. Philips’ telehealth and AI-enabled
data analytics can help support workflows, facilitate remote
collaboration and optimize resources. Philips’ COVID-19-related
solutions are designed for rapid deployment and scalability.
[1] Cheshire and Merseyside is a consortium group of 13 NHS
trusts providing healthcare provision for a population of over 2.5
million people in the
region.[2] https://www.nhsx.nhs.uk/covid-19-response/data-and-covid-19/national-covid-19-chest-imaging-database-nccid/
For further information, please contact:
Joost Maltha Philips Global Press Office Tel.: +31 6 10 55 81 16
E-mail: joost.maltha@philips.com
Emily Wells-BurrIntegrated Communications Manager, Philips
UKITel: 07825 105 685E-mail: emilywellsburr@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Data integration
- NHS data integration hub
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2023 a Mar 2024